From April 2020, in the beginning of the pandemic, to the end of the ACT-A transition period, unprecedented support of
US$ 24bn was committed to the ACT-A agencies by generous donors. The Transition Plan called for US$ 386m in funding for the Therapeutics and Diagnostics Pillars and the Health Systems and Response Connector.

By 17 March 2023, US$ 116.9m had been generously committed by donors, leaving a funding gap of US$ 269.1m.

This unmet need will be carried forward with funds still required by the partner agencies to support the integration of COVID-19 work into core and routine health programmes. This will need to be complemented by additional funding to support the recovery from COVID-19 related setbacks to other critical health services.